Pavla Fajtova

Pavla Fajtova

Auto-generated profile, based on publicly available information

Pavla Fajtova

Center for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2022 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
ZJZhicheng Jin
Zhicheng Jin
YMYash Mantri
Yash Mantri
MRMaurice Retout
Maurice Retout
YCYong Cheng
Yong Cheng
JZJiajing Zhou
Jiajing Zhou
JJJesse V. Jokerst
Jesse V. Jokerst
The transmission of SARS‐CoV‐2 coronavirus has led to the COVID‐19 pandemic. Nucleic acid testing while specific has limitations for mass surveillance. One alternative is the main protease (Mpro) due to its functional importance in mediating the viral life cycle. Here, we describe a combination of modular substrate and gold colloids to detect Mpro via visual readout. The strategy involves zwitterionic peptide that carries opposite charges at the C‐/N‐terminus to exploit the specific recognition by Mpro. Autolytic cleavage releases a positively charged moiety that assembles the nanoparticles with rapid color changes (t<10 min). We determine a limit of detection for Mpro in breath condensate matrices <10 nM. We further assayed ten COVID‐negative subjects and found no false‐positive result. In the light of simplicity, our test for viral protease is not limited to an equipped laboratory, but also is amenable to integrating as portable point‐of‐care devices including those on face‐coverings.

15 December 2022 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
ZJZhicheng Jin
Zhicheng Jin
YLYi Li
Yi Li
KLKe Li
Ke Li
JZJiajing Zhou
Jiajing Zhou
JYJustin Yeung
Justin Yeung
JJJesse V. Jokerst
Jesse V. Jokerst

6 March 2023 in Chemistry – A European Journal
Verified
Journal Article
Closed access
JAjehad almaliti
jehad almaliti
PFPavla Fajtová
Pavla Fajtová
JCJaeson Calla
Jaeson Calla
GLGregory M. LaMonte
Gregory M. LaMonte
MFMudong Feng
Mudong Feng
AOAnthony ODonoghue
Anthony ODonoghue

6 February 2023 in International Journal for Parasitology
Verified
Journal Article
Closed access
KPKristyna Peterkova
Kristyna Peterkova
JVJiří Vorel
Jiří Vorel
JIJana Ilgova
Jana Ilgova
POPavel Ostasov
Pavel Ostasov
PFPavla Fajtova
Pavla Fajtova
JDJan Dvorak
Jan Dvorak

4 October 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
JSJan Silhan
Jan Silhan
PFPavla Fajtova
Pavla Fajtova
JBJitka Bartosova
Jitka Bartosova
BHBrianna M. Hurysz
Brianna M. Hurysz
JAJehad Almaliti
Jehad Almaliti
EBEvzen Boura
Evzen Boura
The proteasome is a proteolytic enzyme complex essential for protein homeostasis in mammalian cells and protozoan parasites like Trichomonas vaginalis (Tv), the cause of the most common, non-viral sexually transmitted disease. Tv and other protozoan 20S proteasomes have been validated as druggable targets for antimicrobials. However, low yields and purity of the native proteasome have hindered studies of the Tv 20S proteasome (Tv20S). We address this challenge by creating a recombinant protozoan proteasome by expressing all seven α and seven β subunits of Tv20S alongside the Ump-1 chaperone in insect cells. The recombinant Tv20S displays biochemical equivalence to its native counterpart, confirmed by various assays. Notably, the marizomib (MZB) inhibits all catalytic subunits of Tv20S, while the peptide inhibitor carmaphycin-17 (CP-17) specifically targets β2 and β5. Cryo-electron microscopy (cryo-EM) unveils the structures of Tv20S bound to MZB and CP-17 at 2.8 Å. These findings explain MZB’s low specificity for Tv20S compared to the human proteasome and demonstrate CP-17’s higher specificity. Overall, these data provide a structure-based strategy for the development of specific Tv20S inhibitors to treat trichomoniasis.

7 February 2023 in Chemical Science
Verified
Journal Article
Open access
PDF file
YCYu-Ci Chang
Yu-Ci Chang
ZJZhicheng Jin
Zhicheng Jin
KLKe Li
Ke Li
JZJiajing Zhou
Jiajing Zhou
WYWonjun Yim
Wonjun Yim
JJJesse V. Jokerst
Jesse V. Jokerst
Electrostatic interactions are a key driving force that mediates colloidal assembly. The Schulze-Hardy rule describes that counterions of high charge valence are easier for nanoparticle coagulation; this relationship has been extensively examined in systems of colloids and simple ions. However, it is unclear how the Schulze-Hardy rule scales when the simple electrolytes are replaced with more sophisticated charge carriers. Here, we designed cationic peptides of varying valency and demonstrate that their charge screening behaviors on anionic gold nanoparticles (AuNPs) follows the six-power relationship in the Schulze-Hardy rule. This finding further inspires a simple yet effective strategy for measuring SARS-CoV-2 main protease (Mpro) via naked eyes. This work provides a unique avenue for fundamental NP disassembly based on the Schulze-Hardy rule and can help design versatile substrates for colorimetric sensing of other proteases.